FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Olga Caamaño

Research Profile

Chemicals & Drugs

Anatomy

Concepts & Ideas

Structure-Activity Relationship

Co-author Network

Publications

TOP 3
Feng Luan; Francisco J Romero-Duran; Matilde Yañez; Nerea Alonso; Olga Caamaño; M Natália D S Cordeiro; Xerardo García-Mera; Humberto González Díaz
TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases.
Francisco Prado-Prado; Matilde Yañez; Nerea Alonso; Olga Caamaño; Manuel Escobar; Xerardo García-Mera; Humberto González Díaz
3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.
Humberto González Díaz; Francisco Prado-Prado; Xerardo García-Mera; Nerea Alonso; Paula Abeijón; Olga Caamaño; Matilde Yáñez; Cristian Munteanu; Alejandro Pazos; María Auxiliadora Dea-Ayuela; María Teresa Gómez-Muñoz; M Magdalena Garijo; José Sansano; Florencio M Ubeira
MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Olga Caamaño (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Feng Luan; Francisco J Romero-Duran; Matilde Yañez; Nerea Alonso; Olga Caamaño; M Natália D S Cordeiro; Xerardo García-Mera; Humberto González Díaz
TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases.
Bioorganic & medicinal chemistry 2013;21(7):1870-9.
2012: Francisco Prado-Prado; Matilde Yañez; Nerea Alonso; Olga Caamaño; Manuel Escobar; Xerardo García-Mera; Humberto González Díaz
3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.
Current topics in medicinal chemistry 2012;12(16):1843-65.
2011: Humberto González Díaz; Francisco Prado-Prado; Xerardo García-Mera; Nerea Alonso; Paula Abeijón; Olga Caamaño; Matilde Yáñez; Cristian Munteanu; Alejandro Pazos; María Auxiliadora Dea-Ayuela; María Teresa Gómez-Muñoz; M Magdalena Garijo; José Sansano; Florencio M Ubeira
MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.
Journal of proteome research 2011;10(4):1698-718.
2011: Vicente Yaziji; David Rodríguez; Hugo Gutierrez de teran; Alberto Coelho; Olga Caamaño; Xerardo García-Mera; José Brea; M Isabel Loza; María Isabel Cadavid; Eddy Sotelo
Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists.
Journal of medicinal chemistry 2011;54(2):457-71.
2010: María Isabel Nieto; María Carmen Balo; José Brea; Olga Caamaño; Franco Fernández; Xerardo García-Mera; Carmen López; M Isabel Loza; José Enrique Rodríguez-Borges; Bernat Vidal
Synthesis and pharmacological evaluation of novel substituted 9-deazaxanthines as A2B receptor antagonists.
European journal of medicinal chemistry 2010;45(7):2884-92.
2010: José Enrique Rodríguez-Borges; Xerardo García-Mera; María Carmen Balo; José Brea; Olga Caamaño; Franco Fernández; Carmen López; M Isabel Loza; María Isabel Nieto
Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
Bioorganic & medicinal chemistry 2010;18(5):2001-9.
2009: María Carmen Balo; José Brea; Olga Caamaño; Franco Fernández; Xerardo García-Mera; Carmen López; M Isabel Loza; María Isabel Nieto; José Enrique Rodríguez-Borges
Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
Bioorganic & medicinal chemistry 2009;17(18):6755-60.
2009: Franco Fernández; Olga Caamaño; M Isabel Nieto; Carmen López; Xerardo García-Mera; Angela Stefanachi; Orazio Nicolotti; M Isabel Loza; Jose Brea; Cristina Esteve; Victor Segarra; Bernat Vidal; Angelo Carotti
1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
Bioorganic & medicinal chemistry 2009;17(10):3618-29.
2008: Carmen Balo; Carmen López; Olga Caamaño; Franco Fernández; Xerardo García-Mera; José Enrique Rodríguez-Borges
Synthesis of novel purinyl-1'-homocarbanucleosides based on a cyclopenta[b]pyrazine system.
Chemical & pharmaceutical bulletin 2008;56(5):654-8.
2007: Isabel Pérez-Castro; Olga Caamaño; Franco Fernández; Marcos García; Carmen López; Erik De Clercq
Synthesis of 4-substituted-1,2,3-triazole carbanucleoside analogues of ribavirin via click chemistry.
Organic & biomolecular chemistry 2007;5(23):3805-13.
2007: Carmen Balo; Carmen López; José Manuel Brea; Franco Fernández; Olga Caamaño
Synthesis and evaluation of adenosine antagonist activity of a series of [1,2,4]triazolo[1,5-c]quinazolines.
Chemical & pharmaceutical bulletin 2007;55(3):372-5.
2003: José Manuel Blanco; Olga Caamaño; Franco Fernández; José Enrique Rodríguez-Borges; Jan Balzarini; Erik De Clercq
Carbocyclic analogues of nucleosides from bis-(Hydroxymethyl)-cyclopentane: synthesis, antiviral and cytostatic activities of adenosine, inosine and uridine analogues.
Chemical & pharmaceutical bulletin 2003;51(9):1060-3.
2002: Antonio Rodríguez Hergueta; María José Figueira; Carmen López; Olga Caamaño; Franco Fernández; José Enrique Rodríguez-Borges
Synthesis of series of 1- and 3-differently substituted xanthines from imidazoles.
Chemical & pharmaceutical bulletin 2002;50(10):1379-82.
2002: M Isabel Nieto; Olga Caamaño; Franco Fernández; Maria Gómez; Jan Balzarini; Erik De Clercq
Synthesis, antiviral and cytostatic activities, of carbocyclic nucleosides incorporating a modified cyclopentane ring. IV. Adenosine and uridine analogues.
Nucleosides, nucleotides & nucleic acids 2002;21(3):243-55.
2001: Olga Caamaño; María José Figueira; Franco Fernández; Marcos García; M Isabel Nieto; Erik De Clercq; Jan Balzarini
Synthesis and evaluation of antiviral activity of higher homologues of xylo-carbocyclic nucleosides.
Nucleosides, nucleotides & nucleic acids 2001;20(4-7):1137-9.
1999: M Isabel Nieto; J Manuel Blanco; Olga Caamaño; Franco Fernández; Xerardo García-Mera; Carmen López; Jan Balzarini; Erik De Clercq
Synthesis and antiviral activity of carbocyclic nucleosides incorporating a modified cyclopentane ring. Part 3: Adenosine and uridine analogues.
Nucleosides & nucleotides 1999;18(10):2253-63.
1999: María José Figueira; José Manuel Blanco; Olga Caamaño; Franco Fernández; Xerardo García-Mera; Carmen López
Synthesis and antiviral and cytostatic activities of carbocyclic nucleosides incorporating a modified cyclobutane ring. Part 1: Guanosine analogues.
Archiv der Pharmazie 1999;332(10):348-52.
1999: José Manuel Blanco; Olga Caamaño; Franco Fernández; Xerardo García-Mera; Antonio Rodríguez Hergueta; Carmen López; José Enrique Rodríguez-Borges; Jan Balzarini; Erik De Clercq
Synthesis and antiviral and antineoplastic activities of some novel carbocyclic guanosine analogues with a cyclobutane ring.
Chemical & pharmaceutical bulletin 1999;47(9):1314-7.
1999: I Nieto; María José Figueira; José Manuel Blanco; Olga Caamaño; Franco Fernández; Erik De Clercq; Jan Balzarini
Synthesis of novel carbocyclic nucleosides with a modified cyclopentane ring and evaluation of their antiviral activity.
Nucleosides & nucleotides 1999;18(4-5):641-2.
1998: M Isabel Nieto; José Manuel Blanco; Olga Caamaño; Franco Fernández; Xerardo García-Mera; Jan Balzarini; E Padalko; J Neyts; Erik De Clercq
Synthesis, antiviral and cytostatic activities of carbocyclic nucleosides incorporating a modified cyclopentane ring. Part 2: Adenosine and uridine analogues.
Nucleosides & nucleotides 1998;17(7):1255-66.